Home Latest Articles
Latest Articles
  • Yun WANG, Jianwei ZHU
    Chinese Journal of Pharmaceuticals. 2022, 53(5): 728-734.
  • Yong YU, Jun YAN, Yongan ZHU, Baiyang CHEN, Shuxia HU, Yiming XU
    Chinese Journal of Pharmaceuticals. 2022, 53(5): 735-739.
  • Ling ZHANG, Yanan WANG, Jiawen ZHU, Rong SHAO, Rong JIANG
    Chinese Journal of Pharmaceuticals. 2022, 53(5): 740-746.
  • Jia ZHU, Tao XU, Cheng WANG, Kailun HE, Qiaofeng TAO
    Chinese Journal of Pharmaceuticals. 2022, 53(5): 747-753.
  • Qiqi ZHANG, Linlin BU, Hong SU
    Chinese Journal of Pharmaceuticals. 2022, 53(5): 754-759.
  • Qiwen ZHENG, Guiliang CHEN, Jian WANG
    Chinese Journal of Pharmaceuticals. 2022, 53(4): 425-438.

    Inhaled drugs are drug-device combination products, which require the cooperation of preparations, devices and patients to achieve desired treatment outcome. Common inhalation devices have problems such as difficult operation skill requirements, low drug availability, and long nebulization time due to their nebulization mechanisms. In terms of these issues, several novel techniques and inhalers are put forward in recent years, such as vibration mesh, soft mist, thermal evaporation atomization, and electrohydrodynamic atomization. Fundamental theory of traditional inhalers and these novel techniques are reviewed in this paper, aiming to provide some inspirations for future inhaler development.

  • Ning FAN, Dongfeng YIN
    Chinese Journal of Pharmaceuticals. 2022, 53(4): 439-445.

    Central nervous system disease is one of the major diseases that significantly affect human health and quality of life. Most drugs cannot cross the blood-brain barrier(BBB), so that their concentrations are too low to completely produce therapeutic effects. Liposomes with special surface modifications can be used as brain-targeted drug carriers to effectively deliver drugs to the brain. This review summarizes the biological properties, BBB crossing mechanisms, and the application of nose-to-brain delivery of brain-targeted liposomes to provide new ideas for drug brain targeting strategies.

  • Xuecheng WANG, Zhenfeng WU, Shijun XU, Zhicheng WU, Ming YANG
    Chinese Journal of Pharmaceuticals. 2022, 53(4): 446-453.

    Drying is one of the most important processes in the manufacture of traditional Chinese medicines, including drying of herbs, extracts and preparations. It is an important research direction of drying of traditional Chinese medicines to explore the drying technology and process that is fast, efficient and can guarantee the quality and clinical efficacy of traditional Chinese medicines. The advantages of low-frequency and high-power ultrasound in enhancing the drying heat and mass transfer process are gradually highlighted, and this technique has a broad application prospect in the field of high quality drying of traditional Chinese medicines. In this paper, the influences of key technological parameters of ultrasonic drying on the drying process and the research status and development trend of typical equipment are analyzed. Meanwhile, the application status and problems of ultrasonic drying in the field of traditional Chinese medicines are discussed and the countermeasures are put forward. It is hoped to provide some references for promoting the theoretical development and industrial application of ultrasound-assisted drying technology.

  • Mingjian LI, Zhiyuan ZHAO, Luyao ZHENG, Lijing SUN, Chengxiao WANG
    Chinese Journal of Pharmaceuticals. 2022, 53(4): 454-463.

    Ionic liquids(ILs) or deep eutectic solvents(DES) are regarded as a kind of green and designable solvents, which emerge as the hot topic in pharmacy because of their excellent solubility, high stability, and simple preparation process. This review illustrates the recent applications of ILs and DES in transdermal drug delivery systems(TDDS). The penetration-enhancing activities of ILs and DES are classified and summarized, their structure-activity relationships for skin permeation are elabrated, and the promising potential of ILs in transdermal immunization and transdermal delivery of nanoparticles is prospected, which could provide a new perspective for further development and application.

  • Fan GE, Jian SUN, Lu HUANG
    Chinese Journal of Pharmaceuticals. 2022, 53(4): 464-473.

    In this study, five small-molecule cyclin-dependent kinase 4/6(CDK4/6) inhibitors, marketed at home and abroad, are analyzed and researched in detail, so does their patent information. To provide practical patent information and references for Chinese pharmaceutical companies to establish and develop projects of CDK4/6 inhibitors for innovative or generic drugs, as well as new patent mining, patent protection and layout, this study mainly focuses on the patents of product, crystalline form, salt form, process, formulation, drug combination, new use and development derivatives.

News